CARGO Therapeutics, Inc. (CRGX) Dividend History

CARGO Therapeutics, Inc. (CRGX) is a biopharmaceutical company focused on developing gene therapy treatments targeting rare and genetic diseases. It specializes in using its proprietary gene delivery platforms to develop innovative therapies aimed at improving patient outcomes in areas with limited treatment options.

835 Industrial Road, Suite 400, San Carlos, CA, 94070
Phone: 650-499-8950
Website: https://www.cargo-tx.com

Dividend History

CARGO Therapeutics, Inc. currently does not pay dividends

Company News

Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week

Cargo Therapeutics, a clinical-stage biotech company, saw its stock price rise by nearly 19% this week after reporting its Q2 earnings. The company's net loss for the quarter was less than expected, and it made progress in its Phase 2 clinical trial for its cancer drug Firi-cel CRG-022.

The Motley Fool
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director

CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director

GlobeNewswire Inc.
CARGO Therapeutics to Participate in Upcoming Investor Conferences

CARGO Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire Inc.
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing

CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing

GlobeNewswire Inc.
What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock

CARGO Therapeutics, Inc. (CRGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research

Dividend data last updated 06/07/2025 05:32:27 UTC